Alert detail
LCD L38586: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer — CGS Administrators
What changed
New LCD for molecular classifiers in bladder cancer testing.
Who’s affected: Oncology billing teams · Effective: May 21, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 6 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.